These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 12411975)

  • 1. The role of low-molecular-weight heparin in cardiovascular diseases.
    Mukherjee D; Topol EJ
    Prog Cardiovasc Dis; 2002; 45(2):139-56. PubMed ID: 12411975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low-molecular-weight heparins for the treatment of acute coronary syndromes.
    Wong GC; Giugliano RP
    Semin Vasc Med; 2003 Nov; 3(4):391-402. PubMed ID: 15199446
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low-molecular-weight heparins in ischemic heart disease.
    Yan AT; Goodman SG
    Curr Opin Cardiol; 2004 Jul; 19(4):309-16. PubMed ID: 15218388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of low-molecular-weight heparins in the management of acute coronary artery syndromes and percutaneous coronary intervention.
    Wong GC; Giugliano RP; Antman EM
    JAMA; 2003 Jan; 289(3):331-42. PubMed ID: 12525234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Low molecular weight heparins in the treatment of unstable angina.
    Ageno W; Turpie AG
    Minerva Cardioangiol; 2002 Dec; 50(6):643-51. PubMed ID: 12473984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low molecular weight heparins in acute ischaemic syndromes.
    White HD; Ellis CJ; French JK
    Aust N Z J Med; 1998 Aug; 28(4):555-7. PubMed ID: 9777139
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Unfractionated and low-molecular-weight heparins in acute coronary syndromes: current recommendations.
    Brener SJ
    Cleve Clin J Med; 2000 Jan; 67(1):59-65. PubMed ID: 10645678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of low-molecular-weight heparins in non-ST-segment elevation acute coronary syndromes.
    Nguyen-Ho P; Levine GN
    Panminerva Med; 2002 Jun; 44(2):115-22. PubMed ID: 12032429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low molecular weight heparins in cardiovascular medicine.
    De Lorenzo F; Dotsenko O; Kakkar VV
    Minerva Cardioangiol; 2005 Dec; 53(6):585-603. PubMed ID: 16333240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The present and future of heparin, low molecular weight heparins, pentasaccharide, and hirudin for venous thromboembolism and acute coronary syndromes.
    Haas S
    Semin Vasc Med; 2003 May; 3(2):139-46. PubMed ID: 15199477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low molecular weight heparin in acute coronary syndromes.
    Cannon CP
    Curr Cardiol Rep; 1999 Sep; 1(3):206-11. PubMed ID: 10980843
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of low-molecular-weight heparins in the management of patients with unstable angina pectoris and non-Q-wave acute myocardial infarction.
    Monrad ES
    Am J Cardiol; 2000 Apr; 85(8A):2C-9C. PubMed ID: 10793174
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of low molecular weight heparins with antiplatelet agents in non-ST elevation acute coronary syndromes: an update.
    Cohen M
    Drugs; 2002; 62(12):1755-70. PubMed ID: 12149045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-molecular-weight heparins in the management of acute coronary syndromes.
    Zed PJ; Tisdale JE; Borzak S
    Arch Intern Med; 1999 Sep; 159(16):1849-57. PubMed ID: 10493315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newer antithrombin agents in acute coronary syndromes.
    Antman EM; Cohen M
    Am Heart J; 1999 Dec; 138(6 Pt 2):S563-9. PubMed ID: 10577463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent clinical trials in the treatment of venous thromboembolism and unstable angina with low molecular weight heparins.
    Hirsh J
    Curr Opin Hematol; 1998 Sep; 5(5):360-5. PubMed ID: 9776217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acute and prolonged treatment with low-molecular-weight heparin therapy in patients with unstable coronary artery disease.
    Husted S; Kher A
    Ann Med; 2000 Dec; 32 Suppl 1():53-9. PubMed ID: 11209983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low-molecular-weight heparins in acute coronary syndromes.
    Korkmaz ME
    Curr Vasc Pharmacol; 2003 Oct; 1(3):259-71. PubMed ID: 15320473
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low molecular weight heparins versus unfractionated heparin for acute coronary syndromes.
    Magee KD; Sevcik W; Moher D; Rowe BH
    Cochrane Database Syst Rev; 2003; (1):CD002132. PubMed ID: 12535430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antithrombotic therapy and the transition to the catheterization laboratory in UA/NSTEMI.
    Ferguson JJ; Wilson JM; Diez J
    Minerva Cardioangiol; 2007 Oct; 55(5):529-56. PubMed ID: 17912162
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.